Asian Journal of Andrology

INVITED REVIEW
Year
: 2019  |  Volume : 21  |  Issue : 3  |  Page : 233--240

The regulatory pathways leading to stem-like cells underlie prostate cancer progression


Chun-Jung Lin, U-Ging Lo, Jer-Tsong Hsieh 
 Department of Urology, UT Southwestern Medical Center, Dallas, TX 75390, USA

Correspondence Address:
Jer-Tsong Hsieh
Department of Urology, UT Southwestern Medical Center, Dallas, TX 75390
USA

Prostate cancer (PCa) is the most common cause of malignancy in males and the third leading cause of cancer mortality in the United States. The standard care for primary PCa with local invasive disease mainly is surgery and radiation. For patients with distant metastases, androgen deprivation therapy (ADT) is a gold standard. Regardless of a favorable outcome of ADT, patients inevitably relapse to an end-stage castration-resistant prostate cancer (CRPC) leading to mortality. Therefore, revealing the mechanism and identifying cellular components driving aggressive PCa is critical for prognosis and therapeutic intervention. Cancer stem cell (CSC) phenotypes characterized as poor differentiation, cancer initiation with self-renewal capabilities, and therapeutic resistance are proposed to contribute to the onset of CRPC. In this review, we discuss the role of CSC in CRPC with the evidence of CSC phenotypes and the possible underlying mechanisms.


How to cite this article:
Lin CJ, Lo UG, Hsieh JT. The regulatory pathways leading to stem-like cells underlie prostate cancer progression.Asian J Androl 2019;21:233-240


How to cite this URL:
Lin CJ, Lo UG, Hsieh JT. The regulatory pathways leading to stem-like cells underlie prostate cancer progression. Asian J Androl [serial online] 2019 [cited 2019 Nov 13 ];21:233-240
Available from: http://www.ajandrology.com/article.asp?issn=1008-682X;year=2019;volume=21;issue=3;spage=233;epage=240;aulast=Lin;type=0